Intranasal Phosphoramidon Increases Beta-Amyloid Levels in Wild-Type and NEP/NEP2-Deficient Mice
Intranasal Phosphoramidon Increases Beta-Amyloid Levels in Wild-Type and NEP/NEP2-Deficient Mice
About this item
Full title
Author / Creator
Publisher
New York: Humana Press Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York: Humana Press Inc
Subjects
More information
Scope and Contents
Contents
Intranasal administration is emerging as a reliable and non-invasive method to bypass the blood–brain barrier and deliver drugs to the brain. This approach has been primarily used to explore therapeutic avenues for neurological diseases. However, intranasal administration could also be used to create animal models of brain disease. Beta-amyloid pep...
Alternative Titles
Full title
Intranasal Phosphoramidon Increases Beta-Amyloid Levels in Wild-Type and NEP/NEP2-Deficient Mice
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_853224929
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_853224929
Other Identifiers
ISSN
0895-8696
E-ISSN
1559-1166
DOI
10.1007/s12031-010-9460-8
